UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Annals of oncology, 2014-09, Vol.25 (9), p.1813-1820

2014

Volltextzugriff (PDF)

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

Annals of oncology, 2017-09, Vol.28 (9), p.2213-2218

2017

Volltextzugriff (PDF)

Development of a selective cell capture and release assay: impact of clustered RGD ligands

Journal of materials chemistry. B, Materials for biology and medicine, 2017-06, Vol.5 (24), p.4745-4753

2017

Volltextzugriff (PDF)

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

British journal of cancer, 2010-04, Vol.102 (8), p.1207-1212

2010

Volltextzugriff (PDF)

2800 Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial UNICANCER ORL03

European journal of cancer (1990), 2015-09, Vol.51, p.S557-S557

2015

Volltextzugriff (PDF)

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

British journal of cancer, 2010-10, Vol.103 (8), p.1173-1181

2010

Volltextzugriff (PDF)

Crise de colique néphrétique par migration d'un fragment de métastase rénale de carcinome épidermoïde laryngé

La revue de medecine interne, 2003, Vol.24 (1), p.67-69

2003

Volltextzugriff (PDF)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

British journal of cancer, 2001-09, Vol.85 (5), p.649-655

2001

Volltextzugriff (PDF)

Traitement des carcinomes épidermoïdes localement évolués des voies aéro-digestives supérieures: place de la radio-chimiothérapie

Oncologie (Paris, France), 2005-06, Vol.7 (4), p.281-285

2005

Volltextzugriff (PDF)

Existe-t-il des critères diagnostiques en faveur d'une fièvre paranéoplasique ?

La revue de medecine interne, 2000-08, Vol.21 (8), p.684-692

2000

Volltextzugriff (PDF)

Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: An EORTC New Drug Development Group Study

European journal of cancer (1990), 2004-12, Vol.40 (18), p.2748-2752

2004

Volltextzugriff (PDF)

Evaluation de la fonction glomérulaire par le dosage de la cystatine C. Absence d'influence de l'état nutritionnel

Immuno-analyse & biologie spécialisée, 2000-07, Vol.15 (4), p.255-257

2000

Volltextzugriff (PDF)

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

JNCI : Journal of the National Cancer Institute, 2009-02, Vol.101 (3), p.142-152

2009

Volltextzugriff (PDF)

Salvage Stereotactic Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S429-S429

2009

Volltextzugriff (PDF)

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy

Journal of clinical oncology, 1996-01, Vol.14 (1), p.268-276

1996

Volltextzugriff (PDF)

Concomitant chemotherapy (CT) and radiotherapy (RT) in advanced squamous cell carcinoma of the head and neck (SCCHN): A pharmacokineticandclinical survey-up date

Radiotherapy and oncology, 2007, Vol.82, p.S53-S54

2007

Volltextzugriff (PDF)

Réirradiation en conditions stéréotaxiques et cetuximab pour des récidives locales de carcinome épidermoïde de la tête et du cou

Cancer radiothérapie, 2010-10, Vol.14 (6), p.620-620

2010

Volltextzugriff (PDF)

Réirradiation en conditions stéréotaxiques de récidives locales de cancers non–épidermoïdes de la tête et du cou

Cancer radiothérapie, 2010-10, Vol.14 (6), p.619-620

2010

Volltextzugriff (PDF)

Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer

Annals of oncology, 1994-05, Vol.5 (5), p.423-426

1994

Volltextzugriff (PDF)

Réirradiation stéréotaxique de rattrapage et cétuximab pour les récidives inopérables de cancers de la tête et du cou

Cancer radiothérapie, 2009-10, Vol.13 (6), p.636-637

2009

Volltextzugriff (PDF)

αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4

Molecular cancer therapeutics, 2016-09, Vol.15 (9), p.2076-2085

2016

Volltextzugriff (PDF)

Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy

The journal of clinical endocrinology and metabolism, 1999-10, Vol.84 (10), p.3545-3550

1999

Volltextzugriff (PDF)

Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)

Annals of oncology, 2016-10, Vol.27, p.vi334-vi334

2016

Volltextzugriff (PDF)

PIK-ORL: A phase II, multicenter trial aiming to evaluate BKM120 in monotherapy in patients (pts) with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC) after failure of platin and cetuximab or anti-EGFR-based therapy

Annals of oncology, 2016-10, Vol.27, p.vi331-vi331

2016

Volltextzugriff (PDF)

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5508-5508

2004

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(238)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Humans
(58)
Life Sciences & Biomedicine
(45)
Technology
(44)
Engineering
(36)
Male
(35)
Female
(33)
Engineering, Electrical & Electronic
(31)
Sciences Biologiques Et Medicales
(27)
Sciences Medicales
(27)
Adult
(24)
Middle Aged
(22)
Physical Sciences
(21)
Aged
(19)
Life Sciences
(19)
Chirurgie . Transplantations, Greffes D'organes Et De Tissus. Pathologie Des Greffons
(18)
Telecommunications
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Oncology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

Development of a selective cell capture and release assay: impact of clustered RGD ligands

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

2800 Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial UNICANCER ORL03

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

Crise de colique néphrétique par migration d'un fragment de métastase rénale de carcinome épidermoïde laryngé

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Traitement des carcinomes épidermoïdes localement évolués des voies aéro-digestives supérieures: place de la radio-chimiothérapie

Existe-t-il des critères diagnostiques en faveur d'une fièvre paranéoplasique ?

Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: An EORTC New Drug Development Group Study

Evaluation de la fonction glomérulaire par le dosage de la cystatine C. Absence d'influence de l'état nutritionnel

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

Salvage Stereotactic Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy

Concomitant chemotherapy (CT) and radiotherapy (RT) in advanced squamous cell carcinoma of the head and neck (SCCHN): A pharmacokineticandclinical survey-up date

Réirradiation en conditions stéréotaxiques et cetuximab pour des récidives locales de carcinome épidermoïde de la tête et du cou

Réirradiation en conditions stéréotaxiques de récidives locales de cancers non–épidermoïdes de la tête et du cou

Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer

Réirradiation stéréotaxique de rattrapage et cétuximab pour les récidives inopérables de cancers de la tête et du cou

αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4

Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy

Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)

PIK-ORL: A phase II, multicenter trial aiming to evaluate BKM120 in monotherapy in patients (pts) with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC) after failure of platin and cetuximab or anti-EGFR-based therapy

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

Suchergebnisse filtern